Skip to main content

Pfizer RSV vaccine for older adults should be monitored for nervous system condition Guillain-Barre, scientists say

Scientists said Pfizer's RSV vaccine for older adults should be monitored for Guillain-Barre, in an article published in the New England Journal of Medicine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.